![]() |
Press Releases August 29, 2006 Protein Sciences Announces Licensing of FluBlok to UNM Pharma for the Japan Market January 9, 2006 Protein Sciences announces closing of $6 million financing and partnership in diabetes vaccine. June 14, 2005 Protein Sciences announces excellent efficacy results for FluBlok, it's recombinant influenza vaccine. October 28, 2004 Protein Sciences Announces FDA Clearance to Conduct Proof of Principle/ Field Trial of FluBlØk™, its Cell-Culture Influenza Vaccine. Enrollment of Subjects to Begin This Week at Three Sites December 12, 2003 Protein Sciences announces election of Jack Van Hulst to the Board of Directors November 18, 2002 Protein Sciences Announces promotion of Drs. Manon M.J. Cox to Chief Operating Officer October 11, 2002 Protein Sciences announces promotion of Dr. Penny Post to Director of Manufacturing June 11, 2002 Protein Sciences announces granting of Trademark Protection for GeneXpress® and expresSF+® June 10, 2002 Protein Sciences announces licensing of patented swine influenza vaccine News Record Journal- April 12, 2007 Report in AMA journal Excited Protein Sciences The Denver Press- April 11, 2007 Flu Vaccine's Worm Turns in Caterpillar Experiment USA Today- April 11, 2007 Flu Vaccine Emerges From Caterpillar Cells Science Daily- April 11, 2007 Pandemic Fears? Try Growing Flu Vaccine Fast in Insect Cells Los Angeles Times- April 10, 2007 HealthDay Reporter- April 10, 2007 Flu Vaccine Grown in Insect Cells Called a Promising Alternative The Record Journal - January 11, 2006 Protein Sciences To Get $6M Boost The Record Journal - December 20, 2005 Protein Sciences chosen The Record Journal - November 5, 2005 Protein Sciences Enlisting Help Of U.S. Congress Officials In Seeking Funding The Record Journal- October 9, 2004 Protein Sciences is in Phase III of new kind of shot The Hartford Courant- October 15, 2004 Suddenly Cinderella Denver Post- October 20, 2004 Flu-vaccine process gets a shot in the arm BioWorld Today- November 1, 2004 Protein Sciences' FluBlØk Moves to Phase II/III Work Bioprocess International- June 2004 Commercial Production in Insect Cells- One Company's Perspective Business Week- January 14, 2004 Biotech's Babies: Doing Well By Doing Good The Hartford Courant- December 26, 2003 For Biotech Firms, A Booster Flu Points To Need For New Vaccines Abcnews.com "Biotech Is Hero of Flu Crisis" |
||||||||||||||||||||||||||||||||||
|
|